77 related articles for article (PubMed ID: 10415022)
1. Requirements for signal delivery through CD44: analysis using CD44-Fas chimeric proteins.
Ishiwatari-Hayasaka H; Fujimoto T; Osawa T; Hirama T; Toyama-Sorimachi N; Miyasaka M
J Immunol; 1999 Aug; 163(3):1258-64. PubMed ID: 10415022
[TBL] [Abstract][Full Text] [Related]
2. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
Liao HX; Lee DM; Levesque MC; Haynes BF
J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
[TBL] [Abstract][Full Text] [Related]
4. Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) invovement.
Lisignoli G; Grassi F; Zini N; Toneguzzi S; Piacentini A; Guidolin D; Bevilacqua C; Facchini A
Arthritis Rheum; 2001 Aug; 44(8):1800-7. PubMed ID: 11508432
[TBL] [Abstract][Full Text] [Related]
5. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.
Liu D; Zhang D; Mori H; Sy MS
Cell Immunol; 1996 Nov; 174(1):73-83. PubMed ID: 8929456
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
7. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis.
Murakami S; Shimabukuro Y; Miki Y; Saho T; Hino E; Kasai D; Nozaki T; Kusumoto Y; Okada H
J Immunol; 1994 Jan; 152(2):467-77. PubMed ID: 7506725
[TBL] [Abstract][Full Text] [Related]
8. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration.
Zhu D; Bourguignon LY
J Cell Physiol; 2000 May; 183(2):182-95. PubMed ID: 10737894
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Sleeman JP; Arming S; Moll JF; Hekele A; Rudy W; Sherman LS; Kreil G; Ponta H; Herrlich P
Cancer Res; 1996 Jul; 56(13):3134-41. PubMed ID: 8674073
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas.
Legembre P; Moreau P; Daburon S; Moreau JF; Taupin JL
Cell Death Differ; 2002 Mar; 9(3):329-39. PubMed ID: 11859415
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Ashany D; Savir A; Bhardwaj N; Elkon KB
J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
[TBL] [Abstract][Full Text] [Related]
12. CD44 triggering enhances human NK cell cytotoxic functions.
Galandrini R; De Maria R; Piccoli M; Frati L; Santoni A
J Immunol; 1994 Nov; 153(10):4399-407. PubMed ID: 7525702
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
[TBL] [Abstract][Full Text] [Related]
14. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
15. The role of CD44 during CD40 ligand-induced dendritic cell clustering and maturation.
Termeer C; Johannsen H; Braun T; Renkl A; Ahrens T; Denfeld RW; Lappin MB; Weiss JM; Simon JC
J Leukoc Biol; 2001 Nov; 70(5):715-22. PubMed ID: 11698490
[TBL] [Abstract][Full Text] [Related]
16. The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding.
Lesley J; English N; Charles C; Hyman R
Eur J Immunol; 2000 Jan; 30(1):245-53. PubMed ID: 10602047
[TBL] [Abstract][Full Text] [Related]
17. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death.
Nakano K; Saito K; Mine S; Matsushita S; Tanaka Y
Apoptosis; 2007 Jan; 12(1):45-54. PubMed ID: 17136494
[TBL] [Abstract][Full Text] [Related]
18. Two different functions for CD44 proteins in human myelopoiesis.
Moll J; Khaldoyanidi S; Sleeman JP; Achtnich M; Preuss I; Ponta H; Herrlich P
J Clin Invest; 1998 Sep; 102(5):1024-34. PubMed ID: 9727071
[TBL] [Abstract][Full Text] [Related]
19. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
20. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation.
DeGrendele HC; Kosfiszer M; Estess P; Siegelman MH
J Immunol; 1997 Sep; 159(6):2549-53. PubMed ID: 9300670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
